GSACGelStat Corp.
Price Chart
Loading chart...
About GelStat Corp. (GSAC)
GelStat Corp. (GSAC) is a Drug Manufacturers - Specialty & Generic company headquartered in Miami, FL, United States whose shares trade over-the-counter on the Pink tier.
GelStat is engaged in research, development, marketing and branding of innovative advanced technology operations. The Company's strategy is to build shareholder value through organic growth and strategic acquisitions.
Products and services
Innovative over the counter consumer healthcare products and advanced technology operations.
GSAC key facts
- Ticker symbol
- GSAC
- Market tier
- Pink
- Sector
- Healthcare
- Headquarters
- Miami, FL, United States
- Country of incorporation
- US
- Year of incorporation
- 2010
- Employees
- 5
- Estimated market cap
- $1.12M (as of Apr 11, 2025)
- Shares outstanding
- 3,740,434,945
- Reporting standard
- U.S. Reporting: SEC Reporting - Reg A
- Audit status
- Audited
- Fiscal year end
- 12/31
- Latest filing
- Quarterly Report (Sep 30, 2021)
GelStat Corp. leadership
- Javier G Acosta — CEO
Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with G
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for GelStat Corp. (GSAC) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Drug Manufacturers - Specialty & Generic Companies on OTC Markets
Other OTC-traded companies in Drug Manufacturers - Specialty & Generic:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...